MDOLL-0229

N/A

Report date: 2024/04/11 17:59:05
NME

Base Information

Drug NameMDOLL-0229
Drug Alias NameMDOLL-0229
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoronavirus replication inhibitorsSARS-CoV-2 macrodomain inhibitors
TargetsSARS-CoV-2 macrodomain
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oulu
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oulu
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A